Replies to post #10 on Candel Therapeutics Inc (CADL)

[axelvento]

Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Nov 10, 2022

https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-reports-third-quarter-2022-financial-results



On December 6, the Company will hold its virtual R&D Day with leadership and renowned oncology experts to present an in-depth overview of the Company’s viral immunotherapy platforms and clinical pipeline including additional data from its phase 2 clinical trial of CAN-2409 in combination with anti-PD-1 or PD-L1 agents in patients with stage III/IV non-small cell lung cancer.